Australia’s biotech industry is on a strong growth trajectory, having grown more than 40% in two years, with the market cap figure of those listed on the ASX up almost $16 billion in six months.
Read the complete article in Stockhead.
Australia’s biotech industry is thriving, with ASX-listed companies up 19% since 2019
Previous
Previous
Food tech startup Vow wants to make Australia a world leader in cultured meat
Next
Next